RhumbLine Advisers’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.06M | Sell |
|
|||||
|
2018
Q2 | $868K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $111K | Buy |
|
|||||
|
2016
Q4 | $109K | Sell |
|
|||||
|
2016
Q3 | $137K | Buy |
|
|||||
|
2016
Q2 | $141K | Sell |
|
|||||
|
2016
Q1 | $182K | Buy |
|
|||||
|
2015
Q4 | $214K | Buy |
|
|||||
|
2015
Q3 | $226K | Buy |
|
|||||
|
2015
Q2 | $242K | Buy |
|
|||||
|
2015
Q1 | $231K | Buy |
|
|||||
|
2014
Q4 | $195K | Buy |
|
|||||
|
2014
Q3 | $183K | Sell |
|
|||||
|
2014
Q2 | $206K | Buy |
|
|||||
|
2014
Q1 | $652K | Sell |
|
|||||
|
2013
Q4 | $309K | Hold |
|
|||||
|
2013
Q3 | $385K | Sell |
|
|||||
|
2013
Q2 | $382K | Buy |
|